Transpire Bio Enters into Exclusive License Agreement with Suzhou Intragrand Pharma for Investigational PDE4 Inhibitor

News Transpire Bio Enters into Exclusive License Agreement with Suzhou Intragrand Pharma for Investigational PDE4 Inhibitor Transpire Bio Inc., a U.S.-based, integrated clinical-stage biopharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, today announced that it has signed an exclusive license agreement with Suzhou Intragrand Pharma Co., Ltd for ITG-1052, an investigational […]

Transpire Bio Announces R&D and Manufacturing Expansion

News Transpire Bio Announces R&D and Manufacturing Expansion Transpire Bio, an integrated clinical-stage biopharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, today announced that it has signed an agreement to expand the footprint of its R&D and Manufacturing capabilities in Pembroke Pines, Florida. The expansion is expected to enhance and build […]

Transpire Bio Strengthens Leadership Team with New Appointments to Lead Commercialization, Quality Assurance, and Manufacturing

News Transpire Bio Strengthens Leadership Team with New Appointments to Lead Commercialization, Quality Assurance, and Manufacturing Transpire Bio, an integrated clinical-stage biopharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, today announced the addition of three distinguished biopharma industry executives to its leadership team. Joining Transpire Bio are Stuart Loesch as Chief […]

Transpire Bio Achieves Important Corporate Milestone with Dosing of First Human Subject in the Company’s Asthma and Chronic Obstructive Pulmonary Disease Inhaled Drug Program

News Transpire Bio Achieves Important Corporate Milestone with Dosing of First Human Subject in the Company’s Asthma and Chronic Obstructive Pulmonary Disease Inhaled Drug Program Transpire Bio, a development-stage pharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, has today announced a definitive agreement with INTO (Inhalation Together) to develop TRB-5, TRB-6 […]

Transpire Bio Expands Access and Innovation in Inhalation Therapies with New Research and Manufacturing Facility

News Transpire Bio Expands Access and Innovation in Inhalation Therapies with New Research and Manufacturing Facility Transpire Bio, a development-stage biopharmaceutical company, was joined by local and state elected officials and industry leaders to celebrate the opening of its new research facility and global headquarters in Weston. Transpire Bio is committed to harnessing the power […]

Transpire Bio announces agreement with INTO for the development of three inhaled medicines

News Transpire Bio announces agreement with INTO for the development of three inhaled medicines Transpire Bio, a development-stage pharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, has today announced a definitive agreement with INTO (Inhalation Together) to develop TRB-5, TRB-6 and TRB-7, inhaled medicines for the treatment of asthma and Chronic […]

Transpire Bio Strengthens Its Leadership Team with a New Senior-Level Appointment

News Transpire Bio Strengthens Its Leadership Team with a New Senior-Level Appointment Transpire Bio, a development-stage pharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, has today announced the addition of another senior-level inhalation expert to their leadership team, filling a key position. Dr. Abhishek Gupta ‘Abhi’ will be assuming the role […]

Transpire Bio announces agreement with Recipharm for the development of an inhaled medicine

News Transpire Bio announces agreement with Recipharm for the development of an inhaled medicine Transpire Bio, a development-stage pharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, has announced a definitive agreement with Recipharm to develop TRB-1 and TRB-2, inhaled medicines for the treatment of asthma and Chronic Obstructive Pulmonary Disease (COPD). […]